APC Protein is a protein involved in key cellular signaling pathways relevant to neurodegenerative diseases. This page provides comprehensive information about its structure, normal biological function, and role in disease pathogenesis.
APC Protein participates in critical cellular processes that, when dysregulated, contribute to neurodegeneration. Understanding this protein's function is essential for developing therapeutic interventions for Alzheimer's disease, Parkinson's disease, and related conditions.
| APC Protein | |
|---|---|
| Protein Name | APC |
| Gene | [APC](/genes/apc) |
| UniProt ID | P25054 |
| PDB Structure | 1T08, 3NM7, 5L4N |
| Molecular Weight | 312 kDa |
| Subcellular Localization | Cytoplasm, Nucleus, Cell junctions |
| Protein Family | Tumor suppressor (Armadillo repeat-containing) |
APC is a large protein with multiple functional domains: an N-terminal oligomerization domain, an armadillo repeat domain that mediates protein-protein interactions, a beta-catenin binding site, a basic domain for microtubule binding, and a C-terminal domain for binding to disc-large (DLG) proteins. The protein can form homodimers and multimers.
APC functions as a tumor suppressor and key regulator of Wnt/beta-catenin signaling. It forms a destruction complex with AXIN, GSK3-beta, and CK1-alpha that phosphorylates beta-catenin, targeting it for ubiquitination and degradation. APC also regulates microtubule dynamics and stability, contributes to cell adhesion and migration, and plays roles in chromosome segregation. At synapses, APC regulates dendritic spine morphology.
Germline APC mutations cause Familial Adenomatous Polyposis (FAP), predisposing to colorectal cancer. In AD, APC expression is altered and the protein interacts with tau and A-beta. APC also regulates genes involved in neuronal survival. Loss of APC in neurons leads to synaptic deficits and neurodegeneration in models.
APC replacement or stabilization strategies are being explored for FAP and cancer. However, given the large size of the protein, gene therapy approaches are challenging. Small molecules that restore APC function or enhance Wnt pathway regulation are in development.